• Contact quintiles

    Phone:+1 866 267 4479

    Request a Proposal

  • Biosimilars

  • clinical-trials-header
  • Quintiles Clinical Trial

    Analysts expect biosimilars to lower drug costs and increase accessibility – creating billions in market potential. But what about the risks?

    Whether your goal is gaining regulatory approval for a product that mimics the active pathway of an existing biologic (biosimilar) or minimizing competitive threats, Quintiles can help.

    Integrated biosimilar solutions to overcome challenges and maximize ROI

    • Optimizing clinical development strategy to ensure speed to market without sacrificing quality
    • Navigating regulatory complexities to adapt as pathways and guidelines are still evolving
    • Selecting high opportunity markets and planning ahead to prove value and maximize uptake
    • Minimizing the risk of exposure to competitive biosimilars
    Launch Interactive Element

  • Realizing the biosimilar promise

  • Quintiles Clinical Trails

    Quintiles’ experts share their insights and vision on the future of biosimilar development and commercialization. Listen here

  • Quintiles Clinical Trails

    Dr. Amar Kureishi, Regional Chief Medical Officer, Asia-Pacific, Quintiles, discusses the main drivers behind the growth of biosimilars, and offers suggestions for biopharmaceutical companies looking to enter the space.
    Listen to podcast